Rivaroxaban or Combo Therapy: A Winner for All Ages? – Medscape
Rivaroxaban or Combo Therapy: A Winner for All Ages? MedscapeRivaroxaban Monotherapy Benefits Those with Atrial Fibrillation, Stable Coronary Artery…
Your Patient’s Smartwatch Could Be a Legal Time Bomb
A few years ago, a patient in her 30s saw Nicholas Dragolea, MBBS, a general practitioner when her…
Most GLP-1 Prescriptions Miss the Mark: Are Yours?
GLP-1 receptor agonists, including semaglutide, are now widely used for weight loss, offering substantial weight reduction, improved metabolic…